home / stock / xgn / xgn news


XGN News and Press, Exagen Inc. From 10/27/20

Stock Information

Company Name: Exagen Inc.
Stock Symbol: XGN
Market: NYSE
Website: exagen.com

Menu

XGN XGN Quote XGN Short XGN News XGN Articles XGN Message Board
Get XGN Alerts

News, Short Squeeze, Breakout and More Instantly...

XGN - Exagen to Announce Third Quarter Financial Results on November 10, 2020

SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced that it will release financial results for the quarter ended September 30, 2020 aft...

XGN - Exagen Showcases Six Scientific Presentations at ACR's First Virtual Annual Meeting in November 2020

SAN DIEGO, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today it will be presenting new scientific research at the American College of ...

XGN - Exagen points to positive economic benefits of Avise

Exagen (XGN) says a new study supports the economic benefits of Avise Lupus testing. Key advancements and findings include that over the four-year time horizon Avise Lupus demonstrated an estimated total direct cost savings of $1,991,152, or $1,991 per patient and year one savings of $65...

XGN - New Data Demonstrates Economic Benefit of Exagen's AVISE® Lupus Test for Payors

SAN DIEGO, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced the publication of a study evaluating the economic benefits AVISE® Lupus testing, titled...

XGN - Exagen inks agreement with Provider Network of America for AVISE tests

Exagen ([[XGN]] -4.6%) has entered into a preferred provider network agreement with Provider Network of America (‘PNOA’).PNOA is a nationwide, direct contracted provider network accessed by 526 payers, which has over 375,000 contracted physicians and 12,000 hospitals and ancilla...

XGN - Exagen Inc. Announces Agreement with Provider Network of America Expanding Access for AVISE® Tests to 8 Million Members

SAN DIEGO, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases, today announced that it has entered into a preferred provider network agreement wit...

XGN - Exagen Appoints Wendy Johnson to Board of Directors

SAN DIEGO, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, is proud to announce the addition of Ms. Wendy S. Johnson as an additional independent member to its Bo...

XGN - Exagen Launches Test to Aid in the Detection of ANCA-Associated Vasculitis (AAV)

SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced the launch of AVISE ® Vasculitis AAV, a new testing panel of individual a...

XGN - Exagen to Participate in 2020 Cantor Fitzgerald Virtual Global Healthcare Conference

SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced that its management team will participate in the Cantor Fitzgerald Virtual Global Healt...

XGN - Exagen Inc. Announces a Collaboration with Hospital for Special Surgery (HSS) for Antiphospholipid Syndrome

SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today a collaboration with Hospital for Special Surgery (HSS) in New York City. This well...

Previous 10 Next 10